Henan Universe Joined Shanghai Haohai Biological Technology

In 2016, Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. Joined Shanghai Haohai Biological Technology（06826.HK, 688366. SH).

Haohai Biological Technology (06826.HK) is a leading company in China focusing on R&D, manufacturing and sales of biomedical materials. We strategically target the fast-growing therapeutic areas in the biomedical materials market including ophthalmology, medical aesthetics and would healing, orthopedics, and anti-adhesion and hemostasis. We currently manufacture intraocular lens (IOL), medical sodium hyaluronate, medical chitosan, medical collage sponge, rhEGF, etc. Based on the sales volume of the Company’s IOL and the number of national cataract surgery cases, the Company has captured about 30% of the IOL market in the PRC. Meanwhile, the market share of Company’s anti-adhesion products, OVD products and orthopedics viscosupplementation products was 49.05%, 45.93%, and 36.21%, respectively.

We believe our R&D capabilities will be the driving force behind our long-term competitiveness, as well as our future growth and development. The Company’s in-house R&D team comprised of more than 200 staff members. In 2017, The Company has been included in the list of National Enterprise Technology Centers. Also, the Company owns one national postdoctoral R&D workstation and one Shanghai municipal academician expert workstation. Haohai Biological Technology had been granted more than 40 invention patents. Moreover, our proprietary medical chitosan and rhEGF was awarded the Second Prize of National Science and Technology Progress” by the State Council.